Trusted News Discovery Since 2008
{{/content}}
Covid vaccine: India begins testing indigenous candidate at PGIMS, Rohtak
Video Credit: HT Digital Content
Published on July 18, 2020 - Duration: 02:50s
Covid vaccine: India begins testing indigenous candidate at PGIMS, Rohtak
Human trials of a Covid vaccine candidate, developed in India, have begun.
Trials of the drug named Covaxin are being conducted at PGIMS, Rohtak.
Bharat Biotech and ICMR's National Institute of Virology, Pune developed Covaxin.
The other trial vaccine developed in India is Zydus Cadila's ZyCov-D.
The trials are being conducted as India's total case tally has crossed 10 lakh-mark.
You are here
Related videos from verified sources
Covid update: International flights ban extends; EU books doses; spike in India 03:09
Video credit: HT Digital Content - Published on July 31, 2020
Vikram Chandra analyses Covid-19 spike in India & other top news 07:49
Video credit: HT Digital Content - Published on July 31, 2020
Covid-19: 'Not herd immunity, vaccine only option,' says govt 05:40
Video credit: HT Digital Content - Published on July 31, 2020